James Lynch

1.5k total citations
19 papers, 1.1k citations indexed

About

James Lynch is a scholar working on Pulmonary and Respiratory Medicine, Pathology and Forensic Medicine and Cardiology and Cardiovascular Medicine. According to data from OpenAlex, James Lynch has authored 19 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 6 papers in Pulmonary and Respiratory Medicine, 5 papers in Pathology and Forensic Medicine and 5 papers in Cardiology and Cardiovascular Medicine. Recurrent topics in James Lynch's work include Lymphoma Diagnosis and Treatment (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Neutropenia and Cancer Infections (3 papers). James Lynch is often cited by papers focused on Lymphoma Diagnosis and Treatment (5 papers), Childhood Cancer Survivors' Quality of Life (3 papers) and Neutropenia and Cancer Infections (3 papers). James Lynch collaborates with scholars based in United States, Sweden and Finland. James Lynch's co-authors include George A. Kaplan, Sarah Wamala, Niklas Krause, Jaakko Tuomilehto, Jukka T. Salonen, Nancy P. Mendenhall, Bradford S. Hoppe, Stella Flampouri, Zuofeng Li and Russell Raymond and has published in prestigious journals such as Journal of the American College of Cardiology, Cancer and Annals of Surgery.

In The Last Decade

James Lynch

19 papers receiving 1.0k citations

Peers

James Lynch
Caroline Main United Kingdom
C. P. Quesenberry United States
R F Gillum United States
Dulcie Kermah United States
Clayton W. Eifler United States
Caroline Main United Kingdom
James Lynch
Citations per year, relative to James Lynch James Lynch (= 1×) peers Caroline Main

Countries citing papers authored by James Lynch

Since Specialization
Citations

This map shows the geographic impact of James Lynch's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James Lynch with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James Lynch more than expected).

Fields of papers citing papers by James Lynch

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James Lynch. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James Lynch. The network helps show where James Lynch may publish in the future.

Co-authorship network of co-authors of James Lynch

This figure shows the co-authorship network connecting the top 25 collaborators of James Lynch. A scholar is included among the top collaborators of James Lynch based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James Lynch. James Lynch is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

19 of 19 papers shown
1.
Vega, Raymond B. Mailhot, Sumit Patel, James Lynch, et al.. (2020). Cost-effectiveness of proton therapy for young adults with mediastinal lymphoma: analysis of an institutional cohort. Klinische Pädiatrie. 1 indexed citations
2.
Murali, Krithika, Vicky Makker, James Lynch, & Susana Banerjee. (2018). From Burnout to Resilience: An Update for Oncologists. American Society of Clinical Oncology Educational Book. 38(38). 862–872. 50 indexed citations
3.
Sachsman, Suzanne M., Stella Flampouri, Zuofeng Li, et al.. (2015). Proton therapy in the management of non-Hodgkin lymphoma. Leukemia & lymphoma. 56(9). 2608–2612. 16 indexed citations
4.
Hoppe, Bradford S., Stella Flampouri, James Lynch, et al.. (2012). Improving the therapeutic ratio in Hodgkin lymphoma through the use of proton therapy.. PubMed. 26(5). 456–9, 462. 14 indexed citations
5.
Hoppe, Bradford S., Stella Flampouri, Zhong Su, et al.. (2012). Effective Dose Reduction to Cardiac Structures Using Protons Compared With 3DCRT and IMRT in Mediastinal Hodgkin Lymphoma. International Journal of Radiation Oncology*Biology*Physics. 84(2). 449–455. 87 indexed citations
6.
Smith, Kristy, Christopher G. Morris, Jessica Kirwan, et al.. (2011). Outcomes of Patients With Non-Hodgkin's Lymphoma Treated With Bexxar With or Without External-Beam Radiotherapy. International Journal of Radiation Oncology*Biology*Physics. 82(3). 1122–1127. 7 indexed citations
7.
Hoppe, Bradford S., Stella Flampouri, Zhong Su, et al.. (2011). Consolidative Involved-Node Proton Therapy for Stage IA-IIIB Mediastinal Hodgkin Lymphoma: Preliminary Dosimetric Outcomes From a Phase II Study. International Journal of Radiation Oncology*Biology*Physics. 83(1). 260–267. 56 indexed citations
8.
Englesbe, Michael J., Linda Brooks, James Kubus, et al.. (2010). A Statewide Assessment of Surgical Site Infection Following Colectomy. Annals of Surgery. 252(3). 514–520. 116 indexed citations
9.
Qualman, Stephen J., James Lynch, Julia A. Bridge, et al.. (2008). Prevalence and clinical impact of anaplasia in childhood rhabdomyosarcoma. Cancer. 113(11). 3242–3247. 49 indexed citations
10.
Demirkazık, Ahmet, Anne Kessinger, James Lynch, et al.. (2002). Effect of prior therapy and bone marrow metastases on progenitor cell content of blood stem cell harvests in breast cancer patients. Biology of Blood and Marrow Transplantation. 8(5). 268–272. 3 indexed citations
11.
Mainwaring, Mark, Lisa M. Rimsza, SF Chen, et al.. (2002). Treatment of Refractory Acute Leukemia with Timed Sequential Chemotherapy Using Topotecan Followed by Etoposide+Mitoxantrone (T-EM) and Correlation with Topoisomerase II Levels. Leukemia & lymphoma. 43(5). 989–999. 12 indexed citations
12.
Wamala, Sarah, James Lynch, & George A. Kaplan. (2001). Women's exposure to early and later life socioeconomic disadvantage and coronary heart disease risk: the Stockholm Female Coronary Risk Study. International Journal of Epidemiology. 30(2). 275–284. 138 indexed citations
13.
Miller, Alan M., Ajit Khosla, James Lynch, et al.. (1998). Durable remission of locally advanced breast cancer with multimodality management. Medical Oncology. 15(2). 89–95. 2 indexed citations
14.
Yang, Byoung‐Chul, et al.. (1998). Increased superoxide anion generation and altered vasoreactivity in rabbits on low-potassium diet. American Journal of Physiology-Heart and Circulatory Physiology. 274(6). H1955–H1961. 38 indexed citations
15.
Lynch, James, Niklas Krause, George A. Kaplan, Jaakko Tuomilehto, & Jukka T. Salonen. (1997). Workplace conditions, socioeconomic status, and the risk of mortality and acute myocardial infarction: the Kuopio Ischemic Heart Disease Risk Factor Study.. American Journal of Public Health. 87(4). 617–622. 118 indexed citations
16.
Salonen, Jukka T., et al.. (1997). Plasma fibrinogen and wall thickness in carotid and femoral arteries: findings from the KIHD study. Fibrinolysis & proteolysis. 11. 35–40. 3 indexed citations
18.
Raymond, Russell, et al.. (1988). Myocardial infarction and normal coronary arteriography: A 10 year clinical and risk analysis of 74 patients. Journal of the American College of Cardiology. 11(3). 471–477. 91 indexed citations
19.
Rosenfeld, Louis, et al.. (1979). Long-term experience with childhood thyroid carcinoma. Journal of Pediatric Surgery. 14(3). 332–335. 19 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026